X4 Pharmaceuticals (XFOR) Operating Margin (QoQ) (2024 - 2025)

X4 Pharmaceuticals (XFOR) Operating Margin (QoQ) (2024 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,222.41 Bn 67,222.13 Bn -
2 Nanobiotix 1,909.44 Bn 1,909.38 Bn -
3 Akari Therapeutics 989.71 Bn 989.71 Bn -
4 BeOne Medicines 472.06 Bn 467.27 Bn 1.35 Bn
5 Vertex Pharmaceuticals 122.10 Bn 114.85 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.00 Bn 61.25 Bn 3.31 Bn
7 Belite Bio 62.68 Bn 62.68 Bn -
8 Argenx Se 55.75 Bn 50.57 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.50 Bn 34.50 Bn 959.66 Mn
10 X4 Pharmaceuticals 167.90 Mn -49.15 Mn 2.20 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 63,573.00
Sep 30, 2025 -22,903.00
Jun 30, 2025 -129,677.00
Mar 31, 2025 245,781.00
Dec 31, 2024 367,013.00
Sep 30, 2024 -1.88 Mn